Human resource development contributes to the creation of outstanding regenerative medicine products

被引:5
作者
Nishigaki, Fusako [1 ,2 ]
Ezoe, Sachikon [3 ]
Kitajima, Hideki [3 ]
Hata, Kenichiro [2 ,4 ]
机构
[1] Astellas Pharma Inc, Regenerat Med Labs, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan
[2] FIRM, Chuo Ku, 2-3-11 Nihonbashi Honcho, Tokyo 1030023, Japan
[3] Osaka Univ Hosp, Dept Med Innovat, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan
[4] Japan Tissue Engn Co Ltd J TEC, Gamagori, Aichi, Japan
来源
REGENERATIVE THERAPY | 2017年 / 7卷
关键词
Regenerative medicine; Human resource; Education; Training; JAPAN; GENE;
D O I
10.1016/j.reth.2017.06.002
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Regenerative medicine is currently the focus of global attention. Countries all around the world are actively working to create new regenerative treatment modalities through pioneering research and novel technologies. This is wonderful news for patients who could not be treated with existing medical options. New venture businesses and companies are being established in regenerative medicine and their rapid industrialization is anticipated. However, to ensure high-quality products, human resources qualified in research and development and the manufacturing of these products are essential. The Forum for Innovative Regenerative Medicine (FIRM) conducted a questionnaire of its industry members to examine the training and hiring of people in research and development, product creation, manufacturing, and more. Regenerative medicine is a brand new field; thus, many different businesses will need to cooperate together. People with a broad range of technical skills, abilities, and knowledge will be in demand, with various levels of expertise, from basic to advanced. (C) 2017, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 50 条
  • [41] Human resources required in the field of regenerative medicine: A follow-up of the Japanese survey in 2015
    Ezoe, Sachiko
    REGENERATIVE THERAPY, 2024, 26 : 541 - 546
  • [42] A Comparison of PMDA and EMA Consultations for Regulatory and Scientific Matters in Drugs and Regenerative Medicine Products
    Hideyuki Kondo
    Toshiki Sugita
    Naoko Ida
    Hiroko Fukushima
    Naoyuki Yasuda
    Therapeutic Innovation & Regulatory Science, 2017, 51 : 355 - 359
  • [43] Challenges and opportunities in the compassionate use of out-of-specification products in autologous regenerative medicine
    Masao Sasai
    Yayoi Kitawaki
    Akihiro Umezawa
    Yoshinori Oie
    Takahiro Kamiya
    Takuji Kawamura
    Yoji Sato
    Satoshi Hosoya
    Hiroyuki Sugawara
    Kazuto Yamada
    Hiroshi Izumoto
    Yoshiyuki Mae
    Tohru Kuroda
    Kiyoshi Okada
    Stem Cell Research & Therapy, 16 (1)
  • [44] A Comparison of PMDA and EMA Consultations for Regulatory and Scientific Matters in Drugs and Regenerative Medicine Products
    Kondo, Hideyuki
    Sugita, Toshiki
    Ida, Naoko
    Fukushima, Hiroko
    Yasuda, Naoyuki
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2017, 51 (03) : 355 - 359
  • [45] Ethics University on Regenerative Medicine - As an Instrument for the Development of Valid Public Opinions?
    Bossert, Sabine
    Werdecker, Lena
    Strech, Daniel
    Neitzke, Gerald
    Dierks, Marie-Luise
    Meyer, Antje
    Hirschberg, Irene
    GESUNDHEITSWESEN, 2020, 82 (11) : E124 - E137
  • [46] Epigenetic reprogramming of cell identity: lessons from development for regenerative medicine
    Basu, Amitava
    Tiwari, Vijay K.
    CLINICAL EPIGENETICS, 2021, 13 (01)
  • [47] Lessons from Retinoblastoma: Implications for Cancer, Development, Evolution, and Regenerative Medicine
    Dyer, Michael A.
    TRENDS IN MOLECULAR MEDICINE, 2016, 22 (10) : 863 - 876
  • [48] Process System Engineering Methodologies Applied to Tissue Development and Regenerative Medicine
    Paim, Agata
    Cardozo, Nilo S. M.
    Pranke, Patricia
    Tessaro, Isabel C.
    CUTTING-EDGE ENABLING TECHNOLOGIES FOR REGENERATIVE MEDICINE, 2018, 1078 : 445 - 463
  • [49] Pharmaceutical design and development of perfluorocarbon nanocolloids for oxygen delivery in regenerative medicine
    Lambert, Eric
    Gorantla, Vijay S.
    Janjic, Jelena M.
    NANOMEDICINE, 2019, 14 (20) : 2697 - 2712
  • [50] Editorial: Tendons and ligaments: development, pathogenesis, tissue engineering, and regenerative medicine
    Ker, Dai Fei Elmer
    Tan, Cheemeng
    Cartmell, Sarah
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2024, 12